|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Hypersensitivity reactions including anaphylaxis |
|
angioedema |
|
arthralgia |
|
chills |
|
drug fever |
|
maculopapular, erythematous, or eczematous eruptions |
|
myalgia |
|
pruritus |
|
urticaria |
|
pneumonitis |
|
Hematologic reactions, specifically granulocytopenia |
|
leukopenia |
|
megaloblastic anemia |
|
thrombocytopenia |
|
neurotoxicity |
|
peripheral neuropathy |
|
Aplastic anemia |
|
benign intracranial hypertension |
|
cyanosis |
|
hemolytic anemia |
|
hepatotoxicity, including hepatitis, cholestatic jaundice, chronic active hepatitis, and hepatic necrosis |
|
optic neuritis |
|
pancreatitis |
|
pseudomembranous colitis |
|
psychological disturbances, such as confusion |
|
mental depression |
|
psychotic reactions |
|
severe skin reactions, including exfoliative dermatitis, erythema multiforme, and Stevens-Johnson syndrome |
|
Gastrointestinal disturbances |
|
headache |
|
Rust-yellow to brown discoloration of urine |
|
transient alopecia |
|
Pseudomembranous colitis |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Anemia |
|
Debilitating disease |
|
Diabetes mellitus |
|
Electrolyte imbalance |
|
Vitamin B deficiency |
|
>> Glucose-6-phosphate dehydrogenase deficiency |
|
Hypersensitivity to nitrofurans |
|
>> Neuropathy, peripheral |
|
>> Pulmonary disease |
|
>> Renal function impairment |
|
|
ADULT DOSE:
|
|
Antibacterial-
Oral, 100 mg every twelve hours for seven days. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Antibacterial-
Children up to 12 years of age: Safety and efficacy have not been established.
Children 12 years of age and older: See Usual adult dose . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|